anti-CXCR4 mRNA vaccine (Massachusetts General Hospital/Brigham and Women’s Hospital)

N/A

Report date: 2025/12/18 17:46:29

Base Information

Drug Nameanti-CXCR4 mRNA vaccine (Massachusetts General Hospital/Brigham and Women’s Hospital)
Drug Alias NamemRNA vaccinetargeting CXCR4 (Massachusetts General Hospital/Brigham and Women’s Hospital)anti-CXCR4 mRNA nanoparticles (Massachusetts General Hospital)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe General Hospital Corporation D/B/A Massachusetts General HospitalThe Brigham and Women's Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A